May 09, 2024CorporateFDA Clears the Individualized Nomogram for Rika Plasma Donation SystemThe latest innovation is anticipated to increase collection volume without increasing collection time
March 19, 2024CorporateTerumo Blood and Cell Technologies partners with CiRA Foundation to develop automated iPS cell manufacturingiPS cell manufacturing organization researchers to integrate Terumo Blood and Cell Technologies’ Quantum Flex, expertise through collaboration
Site Map Show — Site Map Hide — Site Map What’s new News Press Inquiries About Terumo Dear Stakeholders Who We Are Corporate Governance Compliance Regulations and Standards Procurement Activity At a Glance Terumo Group Identity Leadership Team History Terumo’s Purpose Terumo's Response to COVID-19 Education and Training Business Overview TIS Division (Terumo Interventional Systems) Neurovascular Division (MicroVention) Cardiovascular Division (Terumo Cardiovascular)/ HeartSheet Division Vascular Graft Division (Terumo Aortic) Hospital Care Solutions Division Life Care Solutions Division Pharmaceutical Solutions Division Terumo Blood and Cell Technologies Company (Terumo Blood and Cell Technologies) Sustainability Sustainability News Sustainability at the Terumo Group Creating a Diverse and Inclusive Workplace Reducing Environmental Footprint Serving Our Communities Report Library GRI Standards Index Technology From Devices to Solutions Special Movies “Our Solutions” Terumo’s strengths—the 3Ds The Solutions Terumo Aims for Basic Information Research and Development Production and Supply Intellectual Property Investors Management Policy Management Policy Business Risks Disclaimer IR Policy IR Library Financial Statements Presentations Terumo Reports IR Events IR Inquiries Financial Highlights Shareholders & Stock Shareholders Meeting Stock Information Shareholder Return Credit Ratings and Corporate Bond Analyst Coverage Articles of Incorporation Site Quote Terms and Conditions of Use Privacy Policy Social Media Policy